Skip to main content
Premium Trial:

Request an Annual Quote

UCLA Cancer Center Licenses Rosetta's Resolver Software

NEW YORK (GenomeWeb News) — Rosetta Biosoftware has licensed its Resolver data-management software to the University of California, Los Angeles, the company said yesterday.
The school will use the software to handle data and analyze gene expression-profiling projects at the school’s Jonsson Comprehensive Cancer Center.
The JCCC is a treatment center that develops cancer therapies, including the breast cancer drug Herceptin, the company said.
Financial terms of the agreement were not released.

Filed under

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.